Recent FDA approvals and changes.
D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines / Q000009:adverse effects; D002214:Capsules; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004348:Drug Labeling; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors; D006801:Humans; D018894:Reverse Transcriptase Inhibitors; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine; D000099227:Abacavir
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D002214:Capsules; D003521:Cyclopropanes; D015224:Dideoxynucleosides; D016568:Drugs, Generic; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D013607:Tablets; D015215:Zidovudine; D000099227:Abacavir; C098320:efavirenz